Development of Genetic Diagnosis of Congenital Metabolic Disorders -Gene Amplification and Determination of Base Sequences by Synthetic Probes-

先天性代谢障碍基因诊断的进展-合成探针的基因扩增和碱基序列测定-

基本信息

  • 批准号:
    63571109
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1988
  • 资助国家:
    日本
  • 起止时间:
    1988 至 1990
  • 项目状态:
    已结题

项目摘要

Direct cloning using Polymerase Chain Reaction (PCR) and simple determination of base mutation employing biotin-labeled oligonucleotide probes were developed in the first year. Using these methods in the next two years 39 Japanese families with beta-thalassemia (beta-thal) were analyzed in the following strategy : (1) A mutation was determined by direct cloning and subsequent sequence analysis. (2) A pair of biotinylated oligonucleotide probes, specific to normal and thalassemic sequences were synthesized. They were reacted to PCR-amplified DNAs of other patients on a nitrocellulose membrane, which was called "dot-blot hybridization". Thus all the patients were surveyed and easily identified for the same thalassemic mutation. The results for the 39 families were : (1)-31 cap A ->G in 3 families, (2) initiation codon ATG ->GTG in 3, (3) initiation codon ATG->AGG in one (Korean family), (4) codon 24 GGT->GGA in one, (5) codon 26 GAG->AAG(Hb E) in one, (6) IVS-I-130 G->C in one, (7) codon … More 41-42 TTCTTT->TT in 7, (8) codon 90 GAG->TAG in 8, (9) IVS-II-1 G->A in 3, (10) IVS-II-654 C->T in 2, (11) IVS-II-848 in one. (12) codon 110 CTG->CCG in 2, (13) codon 121 GAA ->TAA in 2, (14) codon 127-128 CAGGCT->CCT in 4. Thus 14 kinds of beta-thal mutants were discovered in 39 Japanese (including one Korean) families. These Japanese mutants comprise 20% of the beta-thal mutations reported in the world. It is evident that the simple methods described above enabled us to disclose the genetic abnormalities of Japanese beta-thals in such a short time. These Japanese beta-thal mutations vary (14 types). Among them six are unique to the Japanese. These mutants, therefore, seem to be "neutral" in the evolution. Five are common to Chinese, which might contribute to the investigation on Japanese genetics.The direct cloning was evaluated using many clones analyzed by us. As the study for other inherited disorders gene analyses of Hb H diseases in three Japanese families were performed, and amino acid replacement in Hb Hirosaki, a highly unstable variant, were determined by a base sequences analysis. Less
在第一年开发了使用聚合酶链反应(PCR)的直接克隆和使用生物素标记的寡核苷酸探针的碱基突变的简单测定。在接下来的两年中,使用这些方法,在以下策略中分析了39个日本β-地中海贫血(β-地贫)家系:(1)通过直接克隆和随后的序列分析确定突变。(2)合成了一对特异于正常序列和地中海贫血序列的生物素化寡核苷酸探针。它们与硝酸纤维素膜上其他患者的PCR扩增DNA反应,这被称为“斑点杂交”。因此,所有患者都接受了调查,并很容易确定相同的地中海贫血突变。39个家系的结果为:(1)-31capA → G 3个,(2)起始密码子ATG → GTG 3个,(3)起始密码子ATG → AGG 1个(韩国家系),(4)密码子24 GGT → GGA 1个,(5)密码子26 GAG → AAG(Hb E)1个,(6)IVS-I-130 G → C 1个,(7)密码子24 GGT → GGA 1个,(8)密码子26 GAG → AAG(Hb E)1个。 ...更多信息 41-42 TTCTTT->TT在7中,(8)密码子90 GAG->TAG在8中,(9)IVS-II-1 G->A在3中,(10)IVS-II-654 C->T在2中,(11)IVS-II-848在1中。(12)(13)密码子121 GAA ->TAA;(14)密码子127-128 CAGGCT->CCT。在日本39个家系(包括1个韩国家系)中发现14种β地中海贫血突变体。这些日本突变体占世界上报告的β-地中海突变的20%。显然,上述简单的方法使我们能够在如此短的时间内揭示日本β-突变体的遗传异常。这些日本人的β-地中海突变各不相同(14种)。其中有六种是日本人独有的。因此,这些突变体在进化中似乎是“中性的”。其中5个是中国人共有的,这可能有助于日本遗传学的研究。作为对其他遗传性疾病的研究,对三个日本家族中的Hb H疾病进行了基因分析,并通过碱基序列分析确定了Hb广崎(一种高度不稳定的变异体)中的氨基酸置换。少

项目成果

期刊论文数量(41)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
大庭 雄三: "山口大学病院検査部で同定された異常ヘモグロビンおよびサラセミア症" 山口医学. 39. 575-588 (1990)
Yuzo Ohba:“山口大学医院实验室鉴定出异常血红蛋白和地中海贫血”Yamaguchi Medical。 39. 575-588 (1990)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Hattori: "A new βーthalassemia mutation(initiation codon AtG→GTG)foun in the Japanese" Hemoglobin. (1991)
Y.Hattori:“日本血红蛋白中发现了一种新的 β-地中海贫血突变(起始密码子 AtG→GTG)”(1991 年)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y. Hattori, Y. Yamashiro, Y. Matsuno, Y. Ohba, T. Miyaji, Ku. Yamamoto, Ki. Yamamoto, M. Omine, and I. Shimada.: "beta^+ -Thalassemia (codon 24 GGT->GGA) found in a Japanese." Hemoglobin. 12. 655-660 (1988)
Y. Hattori、Y. Yamashiro、Y. Matsuno、Y. Ohba、T. Miyaji、Ku。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HATTORI Yukio其他文献

HATTORI Yukio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HATTORI Yukio', 18)}}的其他基金

Angiogenesis in human ovary and infertility treatment
人类卵巢的血管生成和不孕症治疗
  • 批准号:
    24791716
  • 财政年份:
    2012
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)

相似海外基金

Development and validation of novel mouse models and expression vectors for characterizing severe alpha-thalassemia pathophysiology and evaluating gene therapy approaches.
开发和验证新型小鼠模型和表达载体,用于表征严重α-地中海贫血病理生理学和评估基因治疗方法。
  • 批准号:
    10659630
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Developing gene therapy strategies to treat alpha thalassemia
开发治疗α地中海贫血的基因治疗策略
  • 批准号:
    10345618
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Developing gene therapy strategies to treat alpha thalassemia
开发治疗α地中海贫血的基因治疗策略
  • 批准号:
    10545021
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
FETAL STEM CELL TRANSPLANTATION FOR ALPHA THALASSEMIA
胎儿干细胞移植治疗α地中海贫血
  • 批准号:
    2430762
  • 财政年份:
    1994
  • 资助金额:
    $ 1.34万
  • 项目类别:
FETAL STEM CELL TRANSPLANTATION FOR ALPHA THALASSEMIA
胎儿干细胞移植治疗α地中海贫血
  • 批准号:
    2230672
  • 财政年份:
    1994
  • 资助金额:
    $ 1.34万
  • 项目类别:
FETAL STEM CELL TRANSPLANTATION FOR ALPHA THALASSEMIA
胎儿干细胞移植治疗α地中海贫血
  • 批准号:
    2230671
  • 财政年份:
    1994
  • 资助金额:
    $ 1.34万
  • 项目类别:
TEST TO SCREEN FOR ALPHA-THALASSEMIA-1 IN ADULTS
成人 A-地中海贫血-1 筛查测试
  • 批准号:
    2222654
  • 财政年份:
    1993
  • 资助金额:
    $ 1.34万
  • 项目类别:
ALPHA THALASSEMIA IN ASSOCIATION WITH SICKLE CELL SYNDROME
与镰状细胞综合征相关的α地中海贫血
  • 批准号:
    3944121
  • 财政年份:
  • 资助金额:
    $ 1.34万
  • 项目类别:
ALPHA THALASSEMIA IN ASSOCIATION WITH SICKLE CELL SYNDROME
与镰状细胞综合征相关的α地中海贫血
  • 批准号:
    3921271
  • 财政年份:
  • 资助金额:
    $ 1.34万
  • 项目类别:
ALPHA THALASSEMIA IN ASSOCIATION WITH SICKLE CELL SYNDROME
与镰状细胞综合征相关的α地中海贫血
  • 批准号:
    4696006
  • 财政年份:
  • 资助金额:
    $ 1.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了